Micaela Schachter/X, Shadi Yaghi/LinkedIn
Nov 9, 2026, 12:45
Shadi Yaghi: Rethinking Antithrombotic Therapy After Stroke
Shadi Yaghi, Professor and Chair of Neurology at Hackensack Meridian Neuroscience Institute at Jersey Shore University Medical Center, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Stroke:Vascular and Interventional Neurology, adding:
“A new era in secondary stroke prevention is on the horizon!
Factor XIa inhibitors represent a potential paradigm shift in antithrombotic therapy for secondary stroke prevention, decreasing AIS without increased bleeding.”
Title: OCEANIC-STROKE: The Wave of the New Antithrombotic Therapy Era
Authors: Micaela Schachter, Shadi Yaghi
Stay updated with Hemostasis Today.
-
Nov 9, 2026, 17:11Ken Kuang: Why Your Calves Are Called Your “Second Heart”?
-
Nov 9, 2026, 17:07Mert Dumantepe: Key Insights From The 8th Abu Dhabi International Vascular Conference
-
Nov 9, 2026, 16:57Amrita Sarkar: Exciting Advances in Hematology and Vascular Research at 54th Annual Philadelphia Workshop
-
Nov 9, 2026, 16:47Joey Boxer Samuels: Prolonged Sitting and Vein Thrombosis
-
Nov 9, 2026, 13:48PF4-ELISA–Negative HIT: Are We Missing a New Class of Anti-PF4 Immunothrombotic Disease?
-
Nov 9, 2026, 13:07Nandini Sadasivam: Gene Therapy for Sickle Cell Disease and Thalassaemia
-
Nov 9, 2026, 13:04Raising Awareness of Bleeding Disorders in Women and Girls – EHC
-
Nov 9, 2026, 12:59Rahul Bohra: Exploring the Complex Mechanisms of Sickle Cell Disease
-
Nov 9, 2026, 12:53Three Years of Movement and Thrombosis Awareness in the Czech Republic – World Thrombosis day